참고문헌
- Dunkel IJ. Retinoblastoma. In: 42nd Annual Meeting of American Society of Clinical Oncology; 2006 Jun 2-6; Atlanta, USA. Alexandria; American Society of Clinical Oncology; 2006:6;591-4.
- Abramson DH, Marr BP, Brodie SE, Dunkel I, Palioura S, Gobin YP. Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review. PLoS One 2012;7:e34120. https://doi.org/10.1371/journal.pone.0034120
- Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, et al. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 2002;133:657-64. https://doi.org/10.1016/S0002-9394(02)01348-X
- Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol 2011;129:732-7. https://doi.org/10.1001/archophthalmol.2011.5
- Peterson EC, Elhammady MS, Quintero-Wolfe S, Murray TG, Aziz-Sultan MA. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors. J Neurosurg 2011;114:1603-8. https://doi.org/10.3171/2011.1.JNS10466
- Uusitalo MS, Van Quill KR, Scott IU, Matthay KK, Murray TG, O'Brien JM. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination. Arch Ophthalmol 2001;119:41-8.
- Atchaneeyasakul LO, Wongsiwaroj C, Uiprasertkul M, Sanpakit K, Thephamongkhol K, Trinavarat A. Prognostic factors and treatment outcomes of retinoblastoma in pediatric patients: a single-institution study. Jpn J Ophthalmol 2009;53:35-9. https://doi.org/10.1007/s10384-008-0614-y
- Parulekar MV. Retinoblastoma: current treatment and future direction. Early Hum Dev 2010;86:619-25. https://doi.org/10.1016/j.earlhumdev.2010.08.022
- Nichols KE, Walther S, Chao E, Shields C, Ganguly A. Recent advances in retinoblastoma genetic research. Curr Opin Ophthalmol 2009;20:351-5. https://doi.org/10.1097/ICU.0b013e32832f7f25
- Shields CL, Shields JA. Diagnosis and management of retinoblastoma. Cancer Control 2004;11:317-27. https://doi.org/10.1177/107327480401100506
- Kim J, Do H, Egbert P. Enucleated eyes after failed intra-arterial infusion of chemotherapy for unilateral retinoblastoma: histopathologic evaluation of vitreous seeding. Clin Ophthalmol 2011;5:1655-8.
- Khetan V, Gupta A, Gopal L. Retinoblastoma: recent trends A mini review based on published literature. Oman J Ophthalmol 2011;4:108-15. https://doi.org/10.4103/0974-620X.91265
- Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Naduvilath TJ. Chemoreduction for unilateral retinoblastoma. Arch Ophthalmol 2002;120:1653-8. https://doi.org/10.1001/archopht.120.12.1653
- Shields CL, Kaliki S, Shah SU, Bianciotto CG, Jabbour P, Shields JA. Effect of intraarterial chemotherapy on retinoblastoma-induced retinal detachment. Retina 2012;32:799-804. https://doi.org/10.1097/IAE.0b013e31823d8e1e
- Klufas MA, Gobin YP, Marr B, Brodie SE, Dunkel IJ, Abramson DH. Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: alternatives to direct ophthalmic artery catheterization. AJNR Am J Neuroradiol 2012;33:1608-14. https://doi.org/10.3174/ajnr.A3019
- Honavar SG, Singh AD, Shields CL, Meadows AT, Demirci H, Cater J, et al. Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol 2002;120:923-31. https://doi.org/10.1001/archopht.120.7.923
- Kaliki S, Shields CL, Shah SU, Eagle RC Jr, Shields JA, Leahey A. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma. Arch Ophthalmol 2011;129:1422-7. https://doi.org/10.1001/archophthalmol.2011.289
- Bianciotto C, Shields CL, Iturralde JC, Sarici A, Jabbour P, Shields JA. Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma. Ophthalmology 2012;119:843-9. https://doi.org/10.1016/j.ophtha.2011.09.040
- Venturi C, Bracco S, Cerase A, Cioni S, Galluzzi P, Gennari P, et al. Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments. Acta Ophthalmol 2012 Jan 23 [Epub]. http://dx.doi.org/10.1111/j.1755-3768.2011.02296.x.
- Shields CL, Bianciotto CG, Jabbour P, Griffin GC, Ramasubramanian A, Rosenwasser R, et al. Intra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complications. Arch Ophthalmol 2011;129:1407-15. https://doi.org/10.1001/archophthalmol.2011.151
피인용 문헌
- Diagnosis & Treatment of Retinoblastoma: Current Review vol.22, pp.1, 2015, https://doi.org/10.15264/cpho.2015.22.1.38
- A review of the literature for intra-arterial chemotherapy used to treat retinoblastoma vol.46, pp.9, 2013, https://doi.org/10.1007/s00247-016-3554-6
- Favorable outcome of alternate systemic and intra-arterial chemotherapy for retinoblastoma vol.33, pp.1, 2013, https://doi.org/10.3109/08880018.2015.1135363